Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Operating Expenses (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Operating Expenses for 3 consecutive years, with $83.9 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 34.24% to $83.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $276.0 million through Dec 2025, down 54.04% year-over-year, with the annual reading at $276.0 million for FY2025, 54.04% down from the prior year.
  • Operating Expenses for Q4 2025 was $83.9 million at Nuvation Bio, up from $66.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $470.5 million in Q2 2024, with the low at $20.2 million in Q1 2024.
  • Average Operating Expenses over 3 years is $81.4 million, with a median of $53.7 million recorded in 2024.
  • The sharpest move saw Operating Expenses surged 1700.44% in 2024, then plummeted 86.0% in 2025.
  • Over 3 years, Operating Expenses stood at $20.8 million in 2023, then surged by 200.11% to $62.5 million in 2024, then surged by 34.24% to $83.9 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $83.9 million, $66.2 million, and $65.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.